OpenCTI-Platform OpenCTI 6.9.7 body cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.1 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in OpenCTI-Platform OpenCTI. This issue affects some unknown processing. The manipulation of the argument body leads to cross site scripting. This vulnerability is referenced as CVE-2026-35212. Remote exploitation of the attack is possible. No exploit is available. It is advisable to upgrade the affected component.
Details
A vulnerability, which was classified as problematic, has been found in OpenCTI-Platform OpenCTI. This issue affects an unknown functionality. The manipulation of the argument body with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
OpenCTI is an open source platform for managing cyber threat intelligence knowledge and observables. Versions prior to 7.260227.0 are vulnerable to XSS in the rendering of email-message observable body data. The content of the body field isn't appropriately sanitized when being rendered. Does require user interaction but could be exploited by someone sharing stix or any of the ingester. This could lead to CSRF and then large scale session theft. Version 7.260227.0 contains a fix.
It is possible to read the advisory at github.com. The identification of this vulnerability is CVE-2026-35212 since 04/01/2026. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
Upgrading to version 7.260227.0 eliminates this vulnerability.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
Website
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: OpenCTI 7.260227.0
Timeline
04/01/2026 CVE reserved06/02/2026 VulDB entry created
06/03/2026 Advisory disclosed
06/07/2026 VulDB entry last update
Sources
Product: github.comAdvisory: GHSA-rg6r-x26x-63vq
Status: Confirmed
CVE: CVE-2026-35212 (🔒)
GCVE (CVE): GCVE-0-2026-35212
GCVE (VulDB): GCVE-100-368075
Entry
Created: 06/03/2026 01:47Updated: 06/07/2026 22:07
Changes: 06/03/2026 01:47 (68), 06/07/2026 22:07 (11)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.